Qelbree (viloxazine) is a non-stimulant prescription medication used to treat attention-deficit hyperactivity disorder (ADHD). It was first approved by the FDA in 2021 for children and adolescents ages 6 to 17, and later expanded to include adults. Because it’s not a stimulant, it doesn’t carry the same risk of abuse or dependence as medications like Adderall or Ritalin, which makes it an appealing option for people who can’t tolerate stimulants or prefer to avoid them.
How Qelbree Works in the Brain
Qelbree belongs to a class of medications that increase the availability of certain brain chemicals involved in focus, attention, and impulse control. Specifically, it blocks the reabsorption of norepinephrine, a neurotransmitter that plays a key role in attention, learning, and mood regulation. It also influences serotonin activity, which helps regulate behavior and emotional stability.
This dual action on both norepinephrine and serotonin distinguishes Qelbree from older non-stimulant options. The result is improved concentration, reduced impulsivity, and better emotional regulation for many people with ADHD, though it can take anywhere from one to six weeks before the full effects become noticeable.
What to Expect With Dosing
For adults, the typical starting dose is 200 mg taken once daily by mouth. From there, a prescriber may increase the dose by 200 mg each week, up to a maximum of 600 mg per day, depending on how well it’s working and how well it’s tolerated. Children start at a lower dose, and adjustments follow a similar weekly schedule.
One practical advantage of Qelbree is that the extended-release capsules can be opened and sprinkled onto soft food like applesauce. This is helpful for children or anyone who has difficulty swallowing pills. The medication is taken once a day, which simplifies the routine compared to short-acting ADHD drugs that require multiple doses.
Common Side Effects
Side effects are fairly common with Qelbree, though they differ between children and adults. In clinical trials, about 3% of children and adolescents discontinued the medication due to side effects, compared to 9% of adults.
In children, the most frequently reported side effects were:
- Sleepiness: 16% (vs. 4% on placebo)
- Decreased appetite: 7%
- Fatigue: 6%
- Nausea: 5%
- Vomiting: 4%
- Irritability: 3%
Adults experienced a somewhat different pattern. Insomnia was the most common complaint, affecting 23% of adult participants compared to 7% on placebo. Headache (17%), nausea (12%), fatigue (12%), decreased appetite (10%), dry mouth (10%), and constipation (6%) were also reported at notably higher rates than placebo.
Heart rate increases of more than 20 beats per minute occurred in 20% to 30% of both children and adults in smaller studies, with higher doses producing more pronounced effects. This is worth mentioning to your prescriber, especially if you have a history of heart-related concerns.
Suicidal Thoughts Warning
Qelbree carries a boxed warning, the FDA’s most serious label, regarding an increased risk of suicidal thoughts and behaviors. In trials involving over 1,000 children and adolescents, 0.9% reported suicidal thoughts or behaviors compared to 0.4% on placebo. Among 189 adults in pre-marketing studies, 1.6% reported suicidal thoughts versus none on placebo. No actual suicidal behaviors occurred in adult trials.
The risk is low in absolute terms, but it means close monitoring is important, especially during the first few weeks of treatment or when the dose changes. Sudden shifts in mood, behavior, or emotional state are the key signals to watch for.
The Caffeine Interaction
One of the more unusual things about Qelbree is that it significantly affects how your body processes caffeine. Qelbree inhibits the liver enzyme responsible for breaking down caffeine, which means a normal cup of coffee can hit much harder than expected. In a clinical study, total caffeine exposure in the body increased roughly fivefold when caffeine was taken alongside Qelbree.
This doesn’t mean you have to eliminate caffeine entirely, but the practical effect is real. Statistical analysis showed that caffeine consumption significantly increased the likelihood of insomnia-related side effects in adults taking Qelbree. If you’re a regular coffee or energy drink consumer, scaling back is worth considering, especially since insomnia is already the most common adult side effect.
How Qelbree Compares to Strattera
Strattera (atomoxetine) has been the most well-known non-stimulant ADHD medication for years, and it’s the natural comparison point for Qelbree. Both medications work by increasing norepinephrine and serotonin levels in the brain, and both carry the same boxed warning about suicidal thoughts.
The differences are mostly practical. Strattera has been available much longer and now comes in a generic form, making it considerably cheaper. Qelbree has no generic version as of now. Strattera tends to show effects within one to two weeks, while Qelbree can take up to six weeks to reach full effectiveness. On the other hand, Qelbree capsules can be opened and sprinkled on food, whereas Strattera capsules must be swallowed whole. Strattera dosing is also weight-based, while Qelbree uses fixed doses that are simpler to manage.
Neither medication is categorically better. The choice between them typically comes down to side effect tolerance, cost considerations, and individual response. Some people who don’t respond well to one may do fine on the other.
Who Qelbree Is Best Suited For
Qelbree fills a specific niche in ADHD treatment. It’s most often considered for people who experience intolerable side effects from stimulants (like anxiety, appetite loss, or sleep disruption), those with a history of substance use that makes stimulant prescriptions risky, or patients who simply prefer a non-stimulant approach. It’s also an option when Strattera hasn’t worked or has caused problematic side effects.
Because it’s only available as a brand-name drug, cost can be a barrier. Insurance coverage varies, and out-of-pocket prices tend to be significantly higher than generic stimulants or generic Strattera. Manufacturer savings programs exist but don’t cover everyone.